Pharma R&D Today

Ideas and Insight supporting all stages of Drug Discovery & Development

Select category
Search this blog
Betsy Davis

Betsy Davis

Senior Strategic Marketing Manager

Connect with Betsy Davis on LinkedIn
Follow Betsy Davis on Twitter
Website:

About the author:

Betsy’s entire marketing career has exclusively focused on the STEM market, with a distinct emphasis on Pharma. During her tenure with Elsevier’s Corporate R&D group, she has managed market segmentation for the pharma and life sciences industry, and launched and manages The Hive, a partnership with a select group of biotech and pharmaceutical start-ups focused on early stage innovation in drug discovery and development. The program promotes collaboration and inspiration across the Pharma & Life Sciences industry. Prior to launching her marketing career, Betsy worked as a management consultant focused on strategy implementation. She holds an MBA from the University of Michigan’s Ross School of Business and a BA from Barnard College of Columbia University.


Posts by Betsy Davis

Assessing the State of the Genomic Revolution

Posted on May 29th, 2017 in Pharma R&D

A few weeks ago, a number of experts in the field of genomics gathered in downtown Manhattan for Sequencing the Genome: Examining Modern Medicine, an event hosted by The Atlantic magazine. Continue reading “Assessing the State of the Genomic Revolution” »

Shouldn’t pharmacovigilance be less painful?

Posted on May 26th, 2017 in Pharmacovigilance

PV white board

Even with advanced information technologies, too many companies and pharmacovigilance practitioners are still living with the pain of having to rely on ineffective and outdated systems and processes. Continue reading “Shouldn’t pharmacovigilance be less painful?” »

Re-Inventing R&D for Precision Medicine

Posted on May 22nd, 2017 in Pharma R&D

Precision medicine first emerged in the late ‘90s. But it was the completion of the Human Genome Project in 2003 that really opened up a world of opportunity in this area because it became possible to test patients for certain biomarkers Continue reading “Re-Inventing R&D for Precision Medicine” »

Overcoming Resistance to Precision Medicines

Posted on May 10th, 2017 in Pharma R&D

Precision medicines, which target specific subgroups of patients bearing particular mutations or symptoms, have demonstrated astounding efficacies and have had great success in areas with limited treatment options. Continue reading “Overcoming Resistance to Precision Medicines” »

  1. 1
  2. 2
  3. 3
  4. 13